Lithium Capsules and Tablets and Mogamulizumab-kpkc Intravenous
Determining the interaction of Lithium Capsules and Tablets and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Capsules and Tablets-Molindone
- Lithium Capsules and Tablets-Mometasone (Oral Inhalation)
- Lithium Capsules and Tablets-Mometasone and Formoterol
- Lithium Capsules and Tablets-Mometasone and formoterol Inhalation
- Lithium Capsules and Tablets-Mometasone Cream
- Lithium Capsules and Tablets-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Lithium Carbonate
- Mogamulizumab-kpkc Intravenous-Lithium Carbonate ER Tablets
- Mogamulizumab-kpkc Intravenous-Lithium Carbonate Tablets
- Mogamulizumab-kpkc Intravenous-Lithium Citrate Syrup
- Mogamulizumab-kpkc Intravenous-Lithium Controlled-Release and Extended-Release Tablets
- Mogamulizumab-kpkc Intravenous-Lithium ER